Suppr超能文献

使用来自大鼠、狗、猴子和人类的胆小管膜囊泡(CMVs)来评估药物跨胆小管膜的转运。

Use of canalicular membrane vesicles (CMVs) from rats, dogs, monkeys and humans to assess drug transport across the canalicular membrane.

作者信息

Shilling A D, Azam F, Kao J, Leung L

机构信息

Drug Safety and Metabolism, Wyeth Research RS3250, 500 Arcola Road, Collegeville, PA 19426, USA.

出版信息

J Pharmacol Toxicol Methods. 2006 May-Jun;53(3):186-97. doi: 10.1016/j.vascn.2005.08.003. Epub 2005 Sep 19.

Abstract

INTRODUCTION

A novel application of a Ultrafree filter cartridge/centrifugation method was evaluated to determine uptake in canalicular membrane vesicles (CMVs) from SD rats, beagle dogs, cynomolgus monkeys (common safety species in the pharmaceutical industry) and humans to assess biliary transport.

METHODS

CMVs prepared from fresh livers of rats, dogs, monkeys and humans (four donors) were characterized for enrichment, basolateral and Golgi contamination and orientation. The presence of MRP2 and p-glycoprotein (P-gp) were confirmed by Western blots. Uptake of [3H]-leukotriene C4 (LTC4) and [3H]-estradiol-17beta-d-glucuronide (E2-Gluc) was determined at a low substrate concentration and/or by kinetic measurements (K(m) and V(max)). Correlation of in vitro data with in vivo findings was achieved by determining the biliary clearance of E2-Gluc in rats after a single i.v. dose and with literature in vivo data for LTC4.

RESULTS

CMVs were highly enriched and minimally contaminated based on marker enzyme activities. Uptake clearance among different species varied by approximately ten-fold (rat > dog = human > monkey) for LTC4 and less than two-fold for E2-Gluc. The lower uptake of LTC4 by human than rat CMVs may be attributed to a higher Km value for human than rat CMVs. Uptake of LTC4 or E2-Gluc by human CMVs showed little inter-subject variability (2-5-fold). Differences in in vitro uptake clearance (10-fold) between LTC4 and E2-Gluc in rat CMVs seemed to correlate with differences in their biliary clearance (4-fold) in rats, consistent with LTC4 and E2-Gluc being a high and a low clearance substrate, respectively.

DISCUSSION

A novel application of a Ultrafree filter cartridge/centrifugation method was developed to determine uptake in CMVs from different preclinical animal safety species and humans, and may represent a useful approach to study the mechanism of biliary excretion during drug discovery and development.

摘要

引言

评估了一种新型的超滤滤器盒/离心法,以确定其在来自SD大鼠、比格犬、食蟹猴(制药行业常用的安全物种)和人类的胆小管膜囊泡(CMV)中的摄取情况,以评估胆汁转运。

方法

对从大鼠、犬、猴和人类(四名供体)新鲜肝脏制备的CMV进行富集、基底外侧和高尔基体污染及方向的表征。通过蛋白质免疫印迹法确认多药耐药相关蛋白2(MRP2)和P-糖蛋白(P-gp)的存在。在低底物浓度下和/或通过动力学测量(米氏常数(Km)和最大反应速度(Vmax))来测定[3H] - 白三烯C4(LTC4)和[3H] - 雌二醇-17β-D-葡萄糖醛酸苷(E2-葡萄糖醛酸)的摄取。通过测定大鼠单次静脉注射剂量后E2-葡萄糖醛酸的胆汁清除率以及与LTC4的体内文献数据,实现体外数据与体内结果的相关性分析。

结果

基于标记酶活性,CMV高度富集且污染极小。不同物种间LTC4的摄取清除率相差约10倍(大鼠>犬=人类>猴),E2-葡萄糖醛酸的摄取清除率相差不到2倍。人类CMV对LTC4的摄取低于大鼠CMV,这可能归因于人类CMV的Km值高于大鼠CMV。人类CMV对LTC4或E2-葡萄糖醛酸的摄取在个体间差异较小(2 - 5倍)。大鼠CMV中LTC4和E2-葡萄糖醛酸的体外摄取清除率差异(10倍)似乎与它们在大鼠体内的胆汁清除率差异(4倍)相关,这与LTC4和E2-葡萄糖醛酸分别为高清除率和低清除率底物一致。

讨论

开发了一种新型的超滤滤器盒/离心法,用于测定不同临床前动物安全物种和人类CMV中的摄取情况,这可能是药物研发过程中研究胆汁排泄机制的一种有用方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验